Y020-1334 Screening compound: 2-(morpholin-4-yl)-6-{[(1-phenyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-3,4-dihydropyrimidin-4-one

Y020-1334 Screening compound: 2-(morpholin-4-yl)-6-{[(1-phenyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-3,4-dihydropyrimidin-4-one
Y020-1334 Screening compound: 2-(morpholin-4-yl)-6-{[(1-phenyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-3,4-dihydropyrimidin-4-one alternative view

Chemical Structure Depiction of ChemDiv screening compound Y020-1334
2-(morpholin-4-yl)-6-{[(1-phenyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-3,4-dihydropyrimidin-4-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y020-1334

Molecular Formula

C16H17N7O2S (C16 H17 N7 O2 S)

Compound Name

2-(morpholin-4-yl)-6-{[(1-phenyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-3,4-dihydropyrimidin-4-one

IUPAC name

2-(morpholin-4-yl)-6-{[(1-phenyl-1H-1234-tetrazol-5-yl)sulfanyl]methyl}-34-dihydropyrimidin-4-one

SMILES

O=C1NC(N2CCOCC2)=NC(CSc2nnnn2-c2ccccc2)=C1

InChI

InChI=1S/C16H17N7O2S/c24-14-10-12(17-15(18-14)22-6-8-25-9-7-22)11-26-16-19-20-21-23(16)13-4-2-1-3-5-13/h1-5,10H,6-9,11H2,(H,17,18,24)

InChI Key

YDFBNIIWZLREHO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD06600527

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

371.42

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.179

Distribution Coefficient, logD

1.152

Water Solubility, LogSw

-2.11

Polar Surface Area

85.922

Acid Dissociation Constant (pKa)

8.60

Base Dissociation Constant (pKb)

0.95

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

31.30

Y020-1334 in Drug Discovery

Included in Screening Libraries

Antifungal Library (16415 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PI3K-Targeted Library (17255 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Agro:
  • Agro
Targets:
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with Y020-1334 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y020-1334?
Check Price and Availability of Y020-1334, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y020-1334 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y020-1334
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y020-1334
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y020-1334 available by request